Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Harvard Bioscience Inc?

Accepted Answer

Según el último estado financiero (Form-10K), Harvard Bioscience Inc tiene un total de activos de $126, una ganancia neta loss de $-12

Question 2

¿Cuáles son los ratios financieros clave para HBIO?

Accepted Answer

El ratio corriente de Harvard Bioscience Inc es 2, el margen neto es -12.76, las ventas por acción son $2.15.

Question 3

¿Cómo se desglosan los ingresos de Harvard Bioscience Inc por segmento o geografía?

Accepted Answer

Harvard Bioscience Inc largest revenue segment is Instruments, Equipment, Software and Accessories, at a revenue of 86,964,000 in the most earnings release.For geography, United States is the primary market for Harvard Bioscience Inc, at a revenue of 41,738,000.

Question 4

¿Es rentable Harvard Bioscience Inc?

Accepted Answer

no, según los últimos estados financieros, Harvard Bioscience Inc tiene una ganancia neta loss de $-12

Question 5

¿Tiene Harvard Bioscience Inc alguna deuda?

Accepted Answer

yes, Harvard Bioscience Inc tiene una deuda de 63

Question 6

¿Cuántas acciones en circulación tiene Harvard Bioscience Inc?

Accepted Answer

Harvard Bioscience Inc tiene un total de acciones en circulación de 44.07

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	88	94	112	113	118	102
Revenue Growth (YoY)	-13%	-16%	-1%	-4%	16%	-12%
Cost of Revenue	38	39	45	51	51	44
Gross Profit	50	54	66	62	67	58
Selling, General & Admin	39	43	46	48	47	43
Research & Development	9	10	11	12	10	8
Operating Expenses	54	60	64	67	64	57
Other Non Operating Income (Expenses)	-1	0	0	0	0	0
Pretax Income	-56	-11	-2	-9	0	-7
Income Tax Expense	0	0	0	0	0	0
Net Income	-57	-12	-3	-9	0	-7
Net Income Growth	470%	300%	-67%	--	-100%	75%
Shares Outstanding (Diluted)	44.3	43.53	42.42	41.4	40.3	38.6
Shares Change (YoY)	2%	3%	2%	3%	4%	2%
EPS (Diluted)	-1.3	-0.28	-0.08	-0.23	-0.01	-0.2
EPS Growth	425%	254%	-65%	2,200%	-95%	67%
Free Cash Flow	4	-1	11	0	0	8
Free Cash Flow Per Share	0.09	-0.02	0.25	0	0	0.2
Gross Margin	56.81%	57.44%	58.92%	54.86%	56.77%	56.86%
Operating Margin	-3.4%	-5.31%	1.78%	-3.53%	2.54%	0%
Profit Margin	-64.77%	-12.76%	-2.67%	-7.96%	0%	-6.86%
Free Cash Flow Margin	4.54%	-1.06%	9.82%	0%	0%	7.84%
EBITDA	3	2	8	3	10	7
EBITDA Margin	3.4%	2.12%	7.14%	2.65%	8.47%	6.86%
D&A For EBITDA	6	7	6	7	7	7
EBIT	-3	-5	2	-4	3	0
EBIT Margin	-3.4%	-5.31%	1.78%	-3.53%	2.54%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Harvard Bioscience Inc (HBIO) Price

HBIO Stock Price Chart

HBIO Income

Follow-Up Questions